• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的分子标记物。

Molecular markers in cancer.

机构信息

Central Molecular Laboratory, Govind Ballabh Pant, Postgraduate Institute of Medical, Education and Research (GIPMER), New Delhi 110002, India.

Central Molecular Laboratory, Govind Ballabh Pant, Postgraduate Institute of Medical, Education and Research (GIPMER), New Delhi 110002, India; Department of Biochemistry, Govind Ballabh Pant, Postgraduate Institute of Medical, Education and Research (GIPMER), New Delhi 110002, India.

出版信息

Clin Chim Acta. 2022 Jul 1;532:95-114. doi: 10.1016/j.cca.2022.05.029. Epub 2022 Jun 3.

DOI:10.1016/j.cca.2022.05.029
PMID:35667477
Abstract

Cancer remains a common health issue having significant socioeconomic burden worldwide. Despite the awareness campaigns, cancer cases continue to increase due to an aging population and lack of early detection biomarkers. Accordingly, much research has focused on non-traditional approaches which include novel imaging modalities and liquid biopsy. In addition, a considerable number of biomacromolecules as well as other biomarkers have been identified to further explore their potential use as diagnostic, prognostic and therapeutic tools. In this review, we provide an update on these new findings and explore their clinical application in cancer.

摘要

癌症仍然是一个常见的健康问题,在全球范围内造成了重大的社会经济负担。尽管开展了宣传活动,但由于人口老龄化和缺乏早期检测生物标志物,癌症病例仍在继续增加。因此,许多研究都集中在非传统方法上,包括新型成像方式和液体活检。此外,已经确定了相当数量的生物大分子以及其他生物标志物,以进一步探索它们作为诊断、预后和治疗工具的潜力。在这篇综述中,我们提供了这些新发现的最新信息,并探讨了它们在癌症中的临床应用。

相似文献

1
Molecular markers in cancer.癌症中的分子标记物。
Clin Chim Acta. 2022 Jul 1;532:95-114. doi: 10.1016/j.cca.2022.05.029. Epub 2022 Jun 3.
2
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.循环游离DNA和循环肿瘤细胞作为一线化疗的晚期非小细胞肺癌患者的预后和预测生物标志物
Int J Mol Sci. 2017 May 11;18(5):1035. doi: 10.3390/ijms18051035.
3
Clinical significance of circulating tumor cells in gastric cancer patients.胃癌患者循环肿瘤细胞的临床意义
Oncotarget. 2017 Apr 11;8(15):25713-25720. doi: 10.18632/oncotarget.14879.
4
The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.液体活检在非小细胞肺癌中的现状与未来:联合四种生物源进行诊断、预后、预测和疾病监测。
Curr Oncol Rep. 2018 Jul 20;20(9):70. doi: 10.1007/s11912-018-0720-z.
5
Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.液体活检在转移性前列腺癌中的发展与应用。
Curr Oncol Rep. 2018 Mar 23;20(4):35. doi: 10.1007/s11912-018-0683-0.
6
Liquid biopsy in CNS tumors: Current status & future perspectives.液体活检在中枢神经系统肿瘤中的应用:现状与展望。
Indian J Pathol Microbiol. 2022 May;65(Supplement):S111-S121. doi: 10.4103/ijpm.ijpm_1058_21.
7
Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.液体活检:癌症循环外泌体长非编码 RNA。
Clin Chim Acta. 2019 Aug;495:331-337. doi: 10.1016/j.cca.2019.04.082. Epub 2019 May 2.
8
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.液体活检在结直肠癌的检测、预后和进展监测前沿。
Mol Cancer. 2022 Mar 25;21(1):86. doi: 10.1186/s12943-022-01556-2.
9
Liquid biopsy: possibilities and limitations in uro-oncology.液体活检:在泌尿肿瘤学中的应用及局限性。
Arch Esp Urol. 2022 Mar;75(2):203-214.
10
Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?液体活检在卵巢癌中应用循环肿瘤 DNA 和细胞:是否已经准备好进入黄金时代?
Cancer Lett. 2020 Jan 1;468:59-71. doi: 10.1016/j.canlet.2019.10.014. Epub 2019 Oct 11.

引用本文的文献

1
Predictive value of ultrasound assessment of axillary and brachial artery parameters for lymph node metastasis in breast cancer patients.超声评估腋窝和肱动脉参数对乳腺癌患者淋巴结转移的预测价值。
Am J Cancer Res. 2025 Mar 15;15(3):1066-1080. doi: 10.62347/EBEI7017. eCollection 2025.
2
[The concept of the liquid biopsy in the treatment of malignant eye tumours].[液体活检在恶性眼肿瘤治疗中的概念]
Ophthalmologie. 2024 Dec;121(12):946-953. doi: 10.1007/s00347-024-02132-3. Epub 2024 Nov 8.
3
A machine learning prediction model for cancer risk in patients with type 2 diabetes based on clinical tests.
基于临床检测的 2 型糖尿病患者癌症风险机器学习预测模型。
Technol Health Care. 2024;32(3):1431-1443. doi: 10.3233/THC-230385.